Clinical Trial Update: Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a combination of haloperidol, droperidol, and ondansetron for cannabis-related hyperemesis in cyclic vomiting syndrome was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cyclic Vomiting Syndrome

Drugs mentioned

• Droperidol (droperidol)
• HALOPERIDOL (HALOPERIDOL LACTATE)
• Ondansetron (ondansetron)

Snippet

Sponsor: Corewell Health South | Conditions: Cyclic Vomiting Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2025-05-21